Long-term performance of endocardial leads with steroid-eluting electrodes

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Steroid-eluting leads are designed to reduce chronic inflammation and improve lead performance in cardiac pacing.
• Long-term data on the efficacy and safety of specific steroid-eluting lead models (Medtronic 4003 and 4503) are crucial for clinical practice.

Purpose of the Study:

• To evaluate the long-term performance of steroid-eluting leads in terms of stimulation thresholds and sensing capabilities.
• To assess the stability of lead parameters over time, up to two years post-implantation.

Main Methods:

• A retrospective analysis of 48 steroid-eluting leads implanted in 39 patients over a three-year period.
• Monitoring of stimulation thresholds (using vario and auto-threshold features) and sensing (P-waves and R-waves) via telemetry and programming.
• Long-term follow-up of up to 12 months for 36 patients.

Main Results:

• Mean stimulation thresholds remained low at 2 years: 0.7 V (atrium) and 0.8 V (ventricle).
• Sensing levels were consistently adequate, allowing for programmable sensitivity settings (e.g., 2.5 mV for P-waves, lowest setting for R-waves).
• No significant changes in stimulation thresholds or sensing were observed after the initial 6-week post-implant period.

Conclusions:

• Steroid-eluting leads provide stable and effective pacing and sensing in both atrial and ventricular applications.
• The observed low stimulation thresholds and good sensing levels are maintained long-term, indicating reliable performance.
• These leads represent a safe and effective option for cardiac pacing, with no significant pacing-related complications noted during the study period.